test gallery

Jul 26, 2004

Editor and Chief Brian Casey hands out another AuntMinnie Minnies award at RSNA 2003

none
Latest in Clinical News
Marijuana
Marijuana use linked to greater coronary plaque burden
July 10, 2026
MRI false positive for additional disease, (top to bottom): A. Index lesion—grade 2 invasive ductal carcinoma; B. MRI lesion two, upper inner quadrant: Stromal sclerosis and columnar cell change; C. MRI lesion three, upper outer quadrant: No ultrasound correlate, no malignancy on follow-up; D. CEM marked background parenchymal enhancement with a unifocal retroareolar lesion demonstrating wash-out on delayed MLO. Images are republished under a Creative Commons license (CC BY 4.0).
CEM on par with MRI for breast cancer diagnosis, local staging
July 10, 2026
Minnie Cast Thumbnail (14)
Ultrasound MinnieCast, Episode 12: AI adds to ultrasound in global maternity care
July 10, 2026
Cancer Target
New PET tracer show promise in neuroblastoma
July 9, 2026
Related Stories
Rsna
Market research reports
RSNA
2004 07 16 13 23 16 706
CT
RFCA for afibrillation evolves with MDCT
2004 07 21 14 38 11 706
CT
Radiologists install PET/CT despite community opposition
2004 07 20 15 51 59 706
CT
Digital subtraction enhances colonic lesions in MRC
More in Clinical News
Marijuana use linked to greater coronary plaque burden
By Will Morton
Marijuana users demonstrated more than double coronary artery calcium scores than nonusers.
July 10, 2026
Marijuana
CEM on par with MRI for breast cancer diagnosis, local staging
By Amerigo Allegretto
CEM alone in a prospective study achieved perfect sensitivity and negative predictive value in diagnosing breast cancer.
July 10, 2026
MRI false positive for additional disease, (top to bottom): A. Index lesion—grade 2 invasive ductal carcinoma; B. MRI lesion two, upper inner quadrant: Stromal sclerosis and columnar cell change; C. MRI lesion three, upper outer quadrant: No ultrasound correlate, no malignancy on follow-up; D. CEM marked background parenchymal enhancement with a unifocal retroareolar lesion demonstrating wash-out on delayed MLO. Images are republished under a Creative Commons license (CC BY 4.0).
Ultrasound MinnieCast, Episode 12: AI adds to ultrasound in global maternity care
By Amerigo Allegretto
Researchers from Google Research share results of a study on an AI ultrasound model estimating gestational age in pregnant women.
July 10, 2026
Minnie Cast Thumbnail (14)
New PET tracer show promise in neuroblastoma
By Will Morton
F-18 mFBG achieved a pooled sensitivity of 97%, compared with 82% for I-123 MIBG.
July 9, 2026
Cancer Target
PreludeDx, Learn Look Locate launch DCIS patient education resource
By AuntMinnie.com staff writers
The patient-centered guide will cover various aspects of DCIS, including recurrence risk and radiation therapy decision-making.
July 9, 2026
Prelude Dx Logo Logo
Philips, U of Washington explore AI for non-contrast breast MRI
By AuntMinnie.com staff writers
University researchers will use Philips' Paradise AI research platform to develop models.
July 9, 2026
Philips Rsna 2021 400
Blue Earth, UCL dose first patient in Ac-225 PSMA prostate trial
By AuntMinnie.com staff writers
The study is evaluating an investigational alpha-emitting PSMA-targeted radiopharmaceutical in prostate cancer patients.
July 9, 2026
Blue Earth Therapeutics Logo
AI ultrasound model accurately estimates gestational age
By Amerigo Allegretto
The model achieved noninferiority compared to standard clinical assessments in healthcare settings based in the U.S. and Africa.
July 9, 2026
Ultrasound In Africa 400
Leo Cancer Care nets $65M to deploy proton therapy system
By AuntMinnie.com staff writers
Stanford Medicine used the system to treat a pediatric brain tumor patient on June 4.
July 8, 2026
Cash Bills
GE HealthCare, Mayo Clinic begin new theranostics trial in Minnesota
By AuntMinnie.com staff writers
First U.S. site to investigate the StarGuide GX SPECT/CT technology.
July 8, 2026
Atom Nuclear Lab Thumb
Philips launches new ultrasound system
By AuntMinnie.com staff writers
The system features AI-powered workflows and is designed for high-volume clinical environments.
July 8, 2026
Alturion
AR-guided localization may sub for CT for early-stage lung cancer
By Amerigo Allegretto
AR-guided localization was noninferior to conventional CT guidance and led to better patient experiences.
July 8, 2026
Lungs 3 D Research 400
Page 1 of 3778
Next Page